IMMUNOGL. SNAKE ANTIVENOM, Middle East (NAVPC) 10ml, amp.

NST DVACIMAS1A1

Valid Article

Former Code(s): DVACZNL0050 DVACIMAS1A DVACIMAS1AME DVACIMAS1A2
The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J06AA03
Anatomical Therapeutic Chemical Classification according to WHOCC
The order of this product needs to be justified and is only acceptable under certain conditions.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   

Add Kit To Wishlist

   

IMMUNOGLOBULIN SNAKE ANTIVENOM, Middle East (NAVPC)

This product is not always available at the central supply level. Contact your HQ advisor and check the specifications if an alternative is offered.

Full Name

NAVPC-Polyvalent

Therapeutic Action

Neutralisation of snake venom

Equine serum globulins

Indications

Treatment of snakebite envenomations from species found in Yemen and the rest of Arabian peninsula:

  • Puff adder (Bitis arietans)
  • Horned desert viper (Cerastes cerastes)
  • Saw-scaled viper (Echis carinatus)
  • Mid-east saw scaled viper (Echis coloratus)
  • Egyptian cobra (Naja haje)
  • Desert black snake (Walterinnesia aegyptia)
Some restricted information has been hidden. Sign in to see this information

Instructions for use

10 ml ampoule

Must be given as IV injection or IV infusion (in .9% NaCl).

Read the manufacturer's instructions.

Precautions for Use

Appropriate medical treatment should always be readily available in case of anaphylactic reactions following the administration of the product.

Storage

  • Keep refrigerated between 2ºC and 8ºC - Protect from sunlight
  • Do not freeze.

(Cf Introduction: Thermosensitive products)